Your browser doesn't support javascript.
loading
Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial.
Jo, Jung Hyun; Kim, Yong-Tae; Choi, Ho Soon; Kim, Ho Gak; Lee, Hong Sik; Choi, Young Woo; Kim, Dong Uk; Lee, Kwang Hyuck; Kim, Eui Joo; Han, Joung-Ho; Lee, Seung Ok; Park, Chang-Hwan; Choi, Eun Kwang; Kim, Jae Woo; Cho, Jae Yong; Lee, Woo Jin; Moon, Hyungsik Roger; Park, Mi-Suk; Kim, Sangjae; Song, Si Young.
Affiliation
  • Jo JH; Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim YT; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Choi HS; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
  • Kim HG; Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Republic of Korea.
  • Lee HS; Department of Gastroenterology, Korea University College of Medicine, Seoul, Republic of Korea.
  • Choi YW; Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Republic of Korea.
  • Kim DU; Division of Gastroenterology and Hepatology, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
  • Lee KH; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim EJ; Division of Gastroenterology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
  • Han JH; Department of Internal Medicine, Chungbuk National University College of Medicine & Chungbuk National University Hospital, Cheongju, South Korea.
  • Lee SO; Department of Internal Medicine, The Research Institute for Medical Science, Jeonbuk National University Medical School, Jeonju, Republic of Korea.
  • Park CH; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Choi EK; Division of Gastroenterology, Department of Internal Medicine, Jeju National University College of Medicine, Jeju, Republic of Korea.
  • Kim JW; Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
  • Cho JY; Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Lee WJ; Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Republic of Korea.
  • Moon HR; Department of Economics, University of Southern California, Los Angeles, CA, USA.
  • Park MS; Department of Economics, Yonsei University, Seoul, Republic of Korea.
  • Kim S; Department of Radiology, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.
  • Song SY; GemVax & KAEL Co., Ltd. 58, Techno 11-ro, Yuseong-gu, Daejeon, Republic of Korea.
Br J Cancer ; 130(1): 163, 2024 Jan.
Article de En | MEDLINE | ID: mdl-38049557

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Br J Cancer Année: 2024 Type de document: Article Pays de publication: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Br J Cancer Année: 2024 Type de document: Article Pays de publication: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM